Health Trials

About this trial

The goal of this randomised feasibility trial is to examine feasibility and acceptability of a co-produced and faith-placed intervention to increase uptake of breast, cervical, bowel, and abdominal aortic aneurysm (AAA) screening among Black communities in the North East of England, Leeds and Scotland, United Kingdom (UK).

Participants will be invited to attend a two-hour workshop at each of the three study sites and will be randomly assigned to either the intervention group or the control group.

This 24-month feasibility study will inform the development of a full-scale randomised-controlled trial co-produced for Black people that uses culturally appropriate messages that support screening for early diagnosis in this underserved group.

Eligibility criteria

Qualifiers

Members of participating churches (North East of England, Leeds, Scotland)

Self-identify as Black,

Female aged 25-74,

Male aged 50-74,

Disqualifiers

Not a member of participating churches (North East of England, Leeds, Scotland).

Individuals who do not self-identify as Black

Do not self-identity as Black

Females aged outside the range of 25-74

Trial design

Treatments tested in this trial

  • Faith-placed intervention to promote breast, cervical, bowel, and AAA screening uptake in Black communities.

Treatment groups

300 Participants
are divided into 2 treatment groups

Locations

3
University of GlasgowG12 8QQ, GlasgowScotland, United Kingdom
Leeds Beckett UniversityLS1 3HE, Leeds United Kingdom
University of SunderlandSR1 3SD, Sunderland United Kingdom

Sponsors and collaborators

University of Sunderland

Lead sponsor

University of Glasgow

Collaborator

Source ClinicalTrials.gov